ELEVATED THYROID STIMULATING HORMONE AS A POTENTIAL BIOMARKER FOR RHEUMATIC IMMUNE-RELATED ADVERSE EVENTS FOLLOWING PD-1 INHIBITOR THERAPY Conference Paper uri icon

authors

  • Liew, DFL
  • Leung, JLY
  • McMaster, C
  • Djukiadmodjo, F
  • Liu, B
  • Cebon, J
  • Frauman, AG
  • Buchanan, RRC

publication date

  • June 1, 2018